Metabolism Review

Gléasanna

An gcuireann monatóireacht gliceamach leanúnach eolas ar

Tá CGManna athraitheach i diaibéiteas. I gcás daoine gan diaibéiteas, tomhaistear go príomha rudaí nach bhfuil tábhacht na n-íomhaíochtaí bunaithe ag aon duine.

Updated 3 min read 24 citations Evidence strength 3/5

Méadar glúcóis agus a n-acmhainní socraithe ar dhromchla comhréidh
Roy Zuo · CC BY-SA 4.0 · Wikimedia Commons

Cad a thomhaistear le CGM

Filimint i leacht idirchill, a sampláil gach cúpla nóiméad, a thiontú go glaisí fola measta. Tá dhá thoradh ann. Tá sé ina dhiaidh glaisí fola ar feadh cúpla nóiméad, rud a bhfuil tábhacht aige nuair a bhíonn luachanna ag athrú go tapa. Agus tá sé calabróidh don raon diaibéiteach, áit a bhfuil riachtanais cruinníochta difriúil ó réiteach ar chreathanna beaga i duine nach bhfágann a glaisí an banda gnáth.

Cad atá bunaithe go maith

I diaibéiteas, tá an cás soiléir. D'athraigh córais dúnta-hybrid torthaí gliceamacha agus síceolaíocha i dttrialacha randamacha [7], agus úsáidtear CGM chun éifeachtaí drugaí ar éagsúlacht a chur i gcomparáid go díreach — empagliflozin i gcomparáid le metformin, mar shampla [2]. Úsáidtear trialacha cealla duille mesenchymal i diaibéiteas mar chuspóir [5]. Is iad seo na hiarratais a tógadh an teicneolaíocht dóibh.

CGM i diaibéiteas

Cad nach bhfuil bunaithe i gcás daoine gan diaibéiteas

Déantar trí éileamh a dhéanamh go rialta agus níl aon tacaíocht trial ann:

  1. Go bhfuil spikes i raon neamh-diaibéiteach díobhálach. Ardaíonn glaisí postprandial tar éis ithe. Sin é an córas ag obair. Níor thaispeáin aon thrial go gcauses gnáth-raon a thrasnú dochar.
  2. Go gcuireann sé feabhas ar thorthaí sláinte do chruinneas. Níor thaispeáin aon thrial randamach i gcás daoine gan diaibéiteas go bhfuil tairbhe ar aon chuspóir crua ó laghdú ar éagsúlacht.
  3. Go n-aithníonn do fhreagairt pearsanta bia atá dona duit. Athraíonn freagairt le codladh, strus, béilí roimhe seo, gníomhaíocht, suíomh an tsensor agus an sensor féin. De ghnáth, ní aontaíonn dhá shensor a chaitheamh go comhoiriúnach go suntasach.

Cad a athraíonn go fírinneach an cuarbhrat

Tá roinnt torthaí soladach agus suimiúil. Tá bricfeasta íseal-carbaihiodráit ag táirgeadh freagairt postprandial níos ísle ná bricfeasta íseal-saill [4] — nach iontas é ach atá léirithe go maith. Athraíonn bricfeasta ard-próitéin an próifíl postprandial [6]. Scrúdaigh trial DASH4D éifeachtaí aiste bia ar rialú gliceamach agus éagsúlacht ar bhealach struchtúrtha [3].

An rud is suimiúla: fuair trial randamach go raibh solas lae nádúrtha le linn uaireanta oifige ag feabhsú rialú glaisí [1]. Is athróg circadian é solas a nochtadh, ní athróg aiste bia é, agus léiríonn sé cé mhéad de rialú glaisí atá lasmuigh de cad a itheann tú. Léamh gaolmhar ar ár suíomh cruthúnas codlata.

Cathain a bhíonn CGM go fírinneach úsáideach gan diaibéiteas

  • Prediabetes, áit a bhfuil tú ag rianú treocht chliniciúil fíor.
  • Comhoiriúnachtaí hipoglaicéime, áit a bhfuil comhoiriúnachtaí a bhaineann le léamha fíor diagnóiseach.
  • Curiosity fíor, a choinnítear go hionraic, le súil réalaíoch ar cad a d'fhéadfadh dhá sheachtain de shonraí a insint duit.
  • Aiseolas iompraíochta, atá an úsáid is cosanta — itheann roinnt daoine níos fearr nuair a bhíonn rud éigin ag faire, agus is cúis bhailí é sin fiú mura bhfuil na sonraí glaisí féin neamh-informative.
Scála meáchain phoiblí ag seasamh ar shráid i bPoznań, an Pholainn
MOs810 · CC BY-SA 3.0 · Wikimedia Commons

Ceisteanna coitianta

An spike glaisí tar éis ithe droch?
Is gnáthfhisiolaíocht é. Níl aon fhianaise a bhaineann le trasnaí postprandial gnáth-raon le dochar i gcás daoine gan diaibéiteas.
An gcaithfidh mé ithe chun mo líne a choinneáil go flat?
Níl aon tacaíocht trial ann do spriocanna líne flat i gcás daoine gan diaibéiteas, agus d'fhéadfadh sé a bheith ina chúis le ithe ró-choimeádta gan ghá.
Cén fáth ar thug an béile céanna torthaí difriúla?
Codladh, strus, gníomhaíocht, béilí roimhe seo, éagsúlacht sensor. Tá athdhéanacht trasna laethanta lag.
An féidir le CGM prediabetes a bhrath?
Féadfaidh sé é a mholadh, ach úsáidtear HbA1c nó tástáil foirceannadh glaisí ó bhéal chun diagnóisiú.
An cruthúnas atá taobh thiar den leathanach seo Bar dhíreach ag taispeáint comhoibriú na 14 foilsithe atá luaite ar an leathanach seo de réir cineál staidéir. 1231randomised trial (12)review (3)other (1)
12 foilsitheanna, 2015–2026. Tá trialacha anseo ach beagán comhoibrithe, mar sin tá torthaí aonair fós an-tábhachtach agus d'fhéadfadh siad a bheith athraitheach. Téarma: liosta luaiteanna féin an leathanach seo, thíos.

References

Every citation below links to the original peer-reviewed record on PubMed or via DOI. Nothing here is a substitute for medical advice.

  1. Effects of short-bout accumulated physical activity and sedentary-break interventions on continuous glucose monitoring metrics in adults with type 2 diabetes: A systematic review and meta-analysis Cao S, Wang H, Zhu Y, et al. · Frontiers in endocrinology · 2026 · Meta-analysis DOIPubMed 42798338Full text
  2. Maternal high-protein/low-glycemic-index diet during pregnancy impairs offspring lipid profile-a randomized controlled trial Mogensen CS, Magkos F, Chabanova E, et al. · European journal of nutrition · 2026 · Randomised controlled trial DOIPubMed 42417833Full text
  3. Natural daylight during office hours improves glucose control and whole-body substrate metabolism Harmsen JF, Habets I, Biancolin AD, et al. · Cell metabolism · 2026 · Randomised controlled trial DOIPubMed 41418772
  4. Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naïve type 2 diabetes: The EMPA-FIT study Lim S, Park CY, Jeong IK, et al. · Journal of diabetes and its complications · 2026 · Randomised controlled trial DOIPubMed 41223492
  5. Interaction of melatonin receptor 1B (MTNR1B) genotype and type of breakfast (protein-enriched v carbohydrate-rich) on postprandial glucose response: a randomised crossover trial King A, Nixon J, Kapellou A, et al. · European journal of clinical nutrition · 2026 · Randomised controlled trial DOIPubMed 42521769
  6. Effect of a Personalized Mobile App on Glucose Control in Adults With Prediabetes and Type 2 Diabetes: Exploratory Pilot Randomized Controlled Trial Lalama E, Csanalosi M, Kabisch S, et al. · JMIR human factors · 2026 · Randomised controlled trial DOIPubMed 42342244Full text
  7. Sleep Optimization to Improve Glycemic Targets in Adults With Type 1 Diabetes: A Randomized Controlled Parallel Intervention Trial Martyn-Nemeth P, Duffecy J, Steffen AD, et al. · Diabetes care · 2026 · Randomised controlled trial DOIPubMed 42149583Full text
  8. Relationship Between Sleep and Meal Timing with Glycemia Parameters in Individuals with Obesity Participating in a Randomized Time-Restricted Eating Study Reutrakul S, Simon SL, Wang Q, et al. · Nutrients · 2026 · Randomised controlled trial DOIPubMed 42280467Full text
  9. Understanding the Metabolic and Endocrine Effects of Macronutrient Boluses in the Context of a Low-Carbohydrate Diet: A Randomized Crossover Study Deru LS, Bailey BW, Hales KE, et al. · Nutrients · 2026 · Randomised controlled trial DOIPubMed 42654249Full text
  10. DASH4D diet for glycemic control and glucose variability in type 2 diabetes: a randomized crossover trial Fang M, Wang D, Rebholz CM, et al. · Nature medicine · 2025 · Randomised controlled trial DOIPubMed 40764427Full text
  11. In-Hospital Diabetes Management by a Diabetes Team and Insulin Titration Algorithms Based on Continuous Glucose Monitoring or Point-of-Care Glucose Testing in Patients With Type 2 Diabetes (DIATEC): A Randomized Controlled Trial Olsen MT, Klarskov CK, Jensen SH, et al. · Diabetes care · 2025 · Randomised controlled trial DOIPubMed 39887698
  12. Use of real-time continuous glucose monitoring in non-critical care insulin-treated inpatients under non-diabetes speciality teams in hospital: A pilot randomized controlled study Thabit H, Rubio J, Karuppan M, et al. · Diabetes, obesity & metabolism · 2024 · Randomised controlled trial DOIPubMed 39169520
  13. Continuous Glucose Monitoring Profiles and Health Outcomes After Dapagliflozin Plus Saxagliptin vs Insulin Glargine Simonson DC, Testa MA, Ekholm E, et al. · The Journal of clinical endocrinology and metabolism · 2024 · Randomised controlled trial DOIPubMed 38412282
  14. Impact of a Low-Carbohydrate Compared with Low-Fat Breakfast on Blood Glucose Control in Type 2 Diabetes: A Randomized Trial Oliveira BF, Chang CR, Oetsch K, et al. · The American journal of clinical nutrition · 2023 · Randomised controlled trial DOIPubMed 37257563
  15. Efficacy of Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Type 2 Diabetes Assessed by Retrospective Continuous Glucose Monitoring Zang L, Li Y, Hao H, et al. · Stem cells translational medicine · 2023 · Randomised controlled trial DOIPubMed 37738447Full text
  16. Effect of a High Protein Diet at Breakfast on Postprandial Glucose Level at Dinner Time in Healthy Adults Xiao K, Furutani A, Sasaki H, et al. · Nutrients · 2022 · Randomised controlled trial DOIPubMed 36615743Full text
  17. Effect of a Hybrid Closed-Loop System on Glycemic and Psychosocial Outcomes in Children and Adolescents With Type 1 Diabetes: A Randomized Clinical Trial Abraham MB, de Bock M, Smith GJ, et al. · JAMA pediatrics · 2021 · Randomised controlled trial DOIPubMed 34633418Full text
  18. Improved Glycemic Control and Variability: Application of Healthy Ingredients in Asian Staples Camps SG, Kaur B, Lim J, et al. · Nutrients · 2021 · Randomised controlled trial DOIPubMed 34578981Full text
  19. Continuous Glucose Monitoring in Very Preterm Infants: A Randomized Controlled Trial Galderisi A, Facchinetti A, Steil GM, et al. · Pediatrics · 2017 · Randomised controlled trial DOIPubMed 28916591
  20. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial Tay J, Luscombe-Marsh ND, Thompson CH, et al. · The American journal of clinical nutrition · 2015 · Randomised controlled trial DOIPubMed 26224300
  21. Continuous Glucose Monitoring for Prediabetes: What Are the Best Metrics? Zahalka SJ, Galindo RJ, Shah VN, et al. · Journal of diabetes science and technology · 2024 · Review DOIPubMed 38629784Full text
  22. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring Yapanis M, James S, Craig ME, et al. · The Journal of clinical endocrinology and metabolism · 2022 · Review DOIPubMed 35094087Full text
  23. Continuous Glucose Monitoring and Physical Activity Schubert-Olesen O, Kröger J, Siegmund T, et al. · International journal of environmental research and public health · 2022 · Review DOIPubMed 36231598Full text
  24. Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study Shah VN, DuBose SN, Li Z, et al. · The Journal of clinical endocrinology and metabolism · 2019 · Journal article DOIPubMed 31127824Full text

This page was translated automatically from English. The citations and numbers are unchanged. Read the English original if anything reads oddly. Read the English original